| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 08/21/2002 | EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 08/20/2002 | US6437150 Compounds having protected hydroxy groups |
| 08/20/2002 | CA2165329C Process for the preparation of n-acetyl neuraminic acid derivatives |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | US20020111509 Containing C17-23 divalent hydrocarbon group containing a bridged cyclic hydrocarbon group, as well as an acid decompsable group |
| 08/15/2002 | US20020110874 Recombinant production of novel polyketides |
| 08/14/2002 | EP1231205A1 Vinylphenylpropionic acid derivatives, processes for production of the derivatives, polymers thereof and radiosensitive resin compositions |
| 08/14/2002 | EP1230207A2 Metathesis syntheses of pheromones or their components |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | CN1364162A Alpha-phenyl-beta-ketosulfone |
| 08/13/2002 | US6433197 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 08/13/2002 | US6433178 3-alkyl-3-phenyl-piperidines |
| 08/08/2002 | WO2002060911A2 C-glucosyl ether lipids |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2001092991A3 Design of polyketide synthase genes |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | US20020107224 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431589A1 C-glucosyl ether lipids |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228057A2 Lactonization process |
| 08/07/2002 | EP0764023B1 Compounds and compositions for administration via oral inhalation or insufflation |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
| 08/06/2002 | US6428950 Culturing glial cells which express apolipoprotein e at known level, contacting cells with compound to be tested, comparing apolipoprotein e expression of glial cells in contact with compound with apolipoprotein e expression in control culture |
| 08/01/2002 | WO2002059342A1 Method of preparing 3-[2-{(methylsulfonyl)oxy}ethoxy]-4-(triphenylmethoxy)-1-butanol, methane sulfonate |
| 08/01/2002 | US20020103388 Process for the preparation of substitued pyranes |
| 08/01/2002 | US20020103387 Compounds which mimic the chemical and biological properties of discodermolide |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | CA2429775A1 Method of preparing 3-[2-{(methylsulfonyl)oxy}ethoxy]-4-(triphenylmethoxy)-1-butanol, methane sulfonate |
| 07/31/2002 | EP1226194A1 Synthesis of copolymers containing anhydrofructose derivatives |
| 07/31/2002 | EP1028952B1 Vinyl ether derivatives |
| 07/30/2002 | US6426418 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| 07/25/2002 | WO2002057251A2 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 07/25/2002 | WO2002057250A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 07/25/2002 | WO2001098238A3 Catalytic hydrogenation of ketones and aldehydes |
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |
| 07/25/2002 | WO2001036048A9 Phorboxazole derivatives for treating cancer |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | US20020099034 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/25/2002 | CA2435371A1 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 07/25/2002 | CA2433835A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/24/2002 | EP1224195A1 C-aryl glucoside sglt2 inhibitors |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/23/2002 | US6423806 Radiation transparent molding materials |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/18/2002 | WO2002055499A1 Intermediates for the synthesis of pyridinoline and preparation thereof |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055460A1 Method and device for the distillative processing of 1,6-hexandiol, 1,5-pentandiol and caprolactone |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2433073A1 Method and device for the distillative processing of 1,6-hexandiol, 1,5-pentandiol and caprolactone |
| 07/17/2002 | CN1358716A Substituted benzopyran anti-fungus compound |
| 07/17/2002 | CN1358704A Pentadial preparation by pipeline method synthesizing pyran from vinylmethyl ether and acrolein |
| 07/16/2002 | US6420573 Processes for preparing 3-arylsulfur hydroxamic acids |
| 07/16/2002 | US6420569 Process for producing pyrone compounds |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/11/2002 | WO2002053562A1 Kojic acid derivative and preparation method thereof |
| 07/11/2002 | WO2002053517A2 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/11/2002 | WO2002053094A2 Method for detoxifying a carbohydrate containing solution |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 07/11/2002 | US20020091210 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen |
| 07/11/2002 | US20020091113 Treatment of septic shock |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | DE10100552A1 Verfahren und Vorrichtung zur destillativen Aufarbeitung von 1,6-Hexandiol, 1,5-Pentandiol ung Caprolacton Method and apparatus for working up by distillation of 1,6-hexanediol, 1,5-pentanediol ung caprolactone |
| 07/11/2002 | CA2433883A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/11/2002 | CA2428351A1 Method for detoxifying a carbohydrate containing solution |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
| 07/09/2002 | US6417229 Enzyme inhibitors |
| 07/09/2002 | CA2191993C Novel synthesis of 19-nor-vitamin d compounds |
| 07/04/2002 | WO2002051828A2 Novel c-glycoside derivatives and use thereof |
| 07/04/2002 | WO2001077097A3 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 07/04/2002 | US20020086949 Quaternary amino acids on solid supports |
| 07/04/2002 | US20020086890 Inhibitors of TNF-alpha converting enzyme; treatment of arthritis, inflammation, inflammatory bowel disease etc, |
| 07/04/2002 | US20020086376 Generation of preferential odor compound; for use in perfumes |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/03/2002 | CN1087011C Process for preparing 1,5-pentanediol |
| 07/02/2002 | US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
| 07/02/2002 | US6414126 C-aryl glucoside SGLT2 inhibitors and method |
| 07/02/2002 | US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 06/26/2002 | EP1105383A4 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 06/26/2002 | CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 06/25/2002 | CA2203878C Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 06/20/2002 | WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/19/2002 | EP1214596A1 Glucose sensing molecules having selected fluorescent properties |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1354046A Catalyst for catalyzing unsymmetrical hetero-Diels-Alder reaction, its preparation and application |
| 06/13/2002 | WO2002046507A2 Onium salts and the use therof as latent acids |
| 06/13/2002 | WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/13/2002 | WO2002046128A2 Quaternary amino acids on solid supports |
| 06/13/2002 | WO2002045750A1 Combination drugs |
| 06/13/2002 | WO2002012220A3 Process for preparing discodermolide and analogues thereof |
| 06/13/2002 | US20020072617 As pesticides and herbicides |
| 06/13/2002 | CA2431133A1 Quaternary amino acids on solid supports |